Researchers say therapy improves stem cell engraftment in umbilical cord blood transplant recipients

A therapy involving a natural compound may improve the ability of stem cells from umbilical cord blood to engraft in patients receiving a stem cell transplant for cancer or other diseases, a phase I clinical trial led by Dana-Farber Cancer Institute scientists indicates.

Read the whole article on Physorg

More from Physorg